These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36073574)

  • 21. miR-6745-TIMP1 axis inhibits cell growth and metastasis in gastric cancer.
    Liu H; Xiang Y; Zong QB; Zhang XY; Wang ZW; Fang SQ; Zhang TC; Liao XH
    Aging (Albany NY); 2021 Nov; 13(21):24402-24416. PubMed ID: 34775375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway.
    Du J; Gong A; Zhao X; Wang G
    Dig Dis Sci; 2022 Apr; 67(4):1260-1270. PubMed ID: 33811565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolving the difference between left-sided and right-sided colorectal cancer by single-cell sequencing.
    Guo W; Zhang C; Wang X; Dou D; Chen D; Li J
    JCI Insight; 2022 Jan; 7(1):. PubMed ID: 34793335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer.
    Lin Y; Chen Q; Liu QX; Zhou D; Lu X; Deng XF; Yang H; Zheng H; Qiu Y
    Cancer Med; 2018 Mar; 7(3):809-819. PubMed ID: 29441725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients.
    Natsume S; Yamaguchi T; Takao M; Iijima T; Wakaume R; Takahashi K; Matsumoto H; Nakano D; Horiguchi SI; Koizumi K; Miyaki M
    Jpn J Clin Oncol; 2018 Jul; 48(7):609-618. PubMed ID: 29767751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 28. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
    Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
    BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
    Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial.
    Tapia Rico G; Price T; Tebbutt N; Hardingham J; Lee C; Buizen L; Wilson K; Gebski V; Townsend A
    Clin Colorectal Cancer; 2019 Jun; 18(2):141-148. PubMed ID: 30713134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
    Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
    Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MELK Accelerates the Progression of Colorectal Cancer via Activating the FAK/Src Pathway.
    Liu G; Zhan W; Guo W; Hu F; Qin J; Li R; Liao X
    Biochem Genet; 2020 Oct; 58(5):771-782. PubMed ID: 32472210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
    Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
    Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disheveled-associated activator of morphogenesis 2 promotes invasion of colorectal cancer by activating PAK1 and promoting MMP7 expression.
    Chen A; Liu Z; Wu Q; Li H
    Genes Genomics; 2021 Aug; 43(8):923-935. PubMed ID: 33974241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent Advances on the Differences between Left- and Right-sided Colorectal Cancer].
    Zhong M; Wu B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Dec; 43(6):980-985. PubMed ID: 34980341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancer.
    Abe Y; Nakayama Y; Katsuki T; Inoue Y; Minagawa N; Torigoe T; Higure A; Sako T; Nagata N; Hirata K
    Asia Pac J Clin Oncol; 2019 Apr; 15(2):e49-e55. PubMed ID: 30270512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy.
    Nasir A; Kaiser HE; Boulware D; Hakam A; Zhao H; Yeatman T; Barthel J; Coppola D
    Clin Colorectal Cancer; 2004 Feb; 3(4):243-7. PubMed ID: 15025797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.